Home / Tech / PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)


Andrea Park / FierceBiotech:

PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente  —  If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold.

News Source link

Check Also

Intel announces launch of ‘independent trust authority’

Continuing with its slew of launches and announcements as part of the two-day Intel Vision …